Becton, Dickinson Expands Single Cell Portfolio for High Dimensional Immunology Research
October 29, 2019
October 29, 2019
FRANKLIN LAKES, New Jersey, Oct. 29 -- Becton, Dickinson and Co., a medical technology company, issued the following edited news release:
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the availability of BD Rhapsody WTA Amplification kit for single-cell analysis on the BD Rhapsody system. The BD Rhapsody WTA Amplification kit can be used in combination with BD AbSeq reagents to simultaneously study the entire transcriptome and protein mar . . .
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the availability of BD Rhapsody WTA Amplification kit for single-cell analysis on the BD Rhapsody system. The BD Rhapsody WTA Amplification kit can be used in combination with BD AbSeq reagents to simultaneously study the entire transcriptome and protein mar . . .